GenTrust LLC Purchases Shares of 18,391 Centene Corporation $CNC

GenTrust LLC purchased a new stake in shares of Centene Corporation (NYSE:CNC) in the 4th quarter, Holdings Channel.com reports. The firm purchased 18,391 shares of the company’s stock, valued at approximately $757,000.

Several other institutional investors have also added to or reduced their stakes in CNC. UniSuper Management Pty Ltd boosted its stake in Centene by 66.0% in the 3rd quarter. UniSuper Management Pty Ltd now owns 85,232 shares of the company’s stock worth $3,041,000 after purchasing an additional 33,875 shares in the last quarter. Oracle Investment Management Inc. acquired a new stake in Centene in the 3rd quarter worth approximately $3,936,000. Packer & Co Ltd acquired a new stake in Centene in the 3rd quarter worth approximately $50,487,000. First Citizens Bank & Trust Co. boosted its stake in Centene by 122.5% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 223,157 shares of the company’s stock worth $7,962,000 after purchasing an additional 122,870 shares in the last quarter. Finally, ARGA Investment Management LP acquired a new stake in Centene in the 3rd quarter worth approximately $21,485,000. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Centene Stock Performance

CNC opened at $53.80 on Friday. Centene Corporation has a 12-month low of $25.08 and a 12-month high of $64.15. The company has a current ratio of 1.12, a quick ratio of 1.10 and a debt-to-equity ratio of 0.76. The firm has a market capitalization of $26.46 billion, a PE ratio of -4.09, a P/E/G ratio of 1.06 and a beta of 0.59. The firm has a 50 day moving average of $38.91 and a two-hundred day moving average of $39.45.

Centene (NYSE:CNC) last posted its quarterly earnings results on Tuesday, April 28th. The company reported $3.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.23 by $1.14. The company had revenue of $49.94 billion during the quarter, compared to analyst estimates of $47.53 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. Centene’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period last year, the firm posted $2.90 EPS. On average, analysts anticipate that Centene Corporation will post 3.4 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently commented on CNC shares. Argus upgraded shares of Centene to a “hold” rating in a research note on Monday, February 9th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Centene from $39.00 to $53.00 and gave the stock a “hold” rating in a research note on Wednesday. Sanford C. Bernstein reissued an “outperform” rating and set a $59.00 price target on shares of Centene in a research report on Tuesday, January 6th. JPMorgan Chase & Co. reduced their price target on shares of Centene from $45.00 to $41.00 and set a “neutral” rating for the company in a research report on Thursday, March 19th. Finally, Cantor Fitzgerald raised shares of Centene from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $41.00 to $60.00 in a research report on Tuesday. Six equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $51.41.

Trending Headlines about Centene

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Q1 earnings beat and upgraded outlook — Centene reported stronger-than-expected Q1 results and raised guidance, improving margin visibility and prompting optimism about 2026–2027 recovery prospects. Article Title
• Positive Sentiment: Truist reiterates/raises stance to Buy — Truist moved to a Buy rating with a higher $58 target after the earnings beat, signaling conviction among some buy?side analysts. Article Title
• Positive Sentiment: Multiple upgrades/favorable analyst commentary — Bank of America upgraded CNC to Buy with a $60 target; Cantor Fitzgerald and other boutiques also raised ratings/targets after Q1. These calls support upside sentiment. Article Title
• Neutral Sentiment: UBS raised its price target to $55 but kept a Neutral rating — higher PTs broadly reflect improved forecasts, though many firms still rate CNC neutral/hold. Article Title
• Neutral Sentiment: Jefferies, Morgan Stanley, Mizuho, Deutsche Bank raised targets but maintained Hold/Equal Weight/Neutral ratings — these moves tighten analyst valuation ranges but leave consensus mixed on near?term upside. Article Title Article Title Article Title Article Title
• Neutral Sentiment: Market commentary sees a potential momentum reversal into 2027 — bullish longer?term narrative but recommends watching execution and margin trends. Article Title
• Negative Sentiment: Proposed Medicare Advantage reform (H.R. 8375) introduces transparency, real?time auth and stricter oversight — if enacted, these changes could raise compliance/operational costs for MAOs like Centene and pressure margins over time. Legislative timing and details remain uncertain. Article Title

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.